News
-
Powder characterization specialist Freeman Technology has reached an agreement with distribution partner DKSH to expand into China. DKSH already distributes Freeman’s FT4 Powder Rheometer in Singapore, Malaysia, Thailand and Taiwan and will now distribute the… Read more . . .
-
Gateway Analytical has added new analytical testing and consulting services for OINDPs, the company has announced. New services include identification and particle size distribution (PSD) analysis of agglomerated materials and assessment of agglomerates’ effect on… Read more . . .
-
The organizers of Drug Delivery to the Lungs (DDL) 23, which will take place December 5-7 at the Edinburgh International Conference Centre in Edinburgh, UK, are preparing to accommodate a record number of attendees. .… Read more . . .
-
An article posted on October 4, 2012 on the BMJ publication Drug and Therapeutics Bulletin article asks, “who needs teaching?” when it comes to inhaler technique. The article points out that an overwhelming number of… Read more . . .
-
MannKind Corporation says that it has completed recruitment of patients for two Phase 3 studies of Afrezza inhaled insulin. One of the studies will assess HbA1c levels in Type 1 diabetes patients using either injected… Read more . . .
-
Malvern Instruments has launched the Morphologi G3-ID particle characterization system, which combines Raman spectroscopy with particle imaging to provide simultaneous identification of particle size, particle shape, and chemical composition. According to the company, the system… Read more . . .
-
OptiNose has announced results of a randomized, single-dose, four-way cross-over PK study demonstrating that 20% less of its intranasal dry powder sumatriptan product delivered into the nose than Imitrex nasal spray resulted in over 60%… Read more . . .
-
Fresenius Kabi has announced the availability of 30 ml vials acetylcysteine inhalation solution, 20%, helping to alleviate a shortage of the product in the US. The company is marketing the inhalation solution in the US… Read more . . .
-
As expected, the European Commission has approved Novartis’s Seebri Breezhaler glycopyrronium bromide DPI for the treatment of COPD. The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) issued a positive recommendation for… Read more . . .
-
MicroDose Therapeutx has completed the Phase 1 clinical program for its inhaled antiviral fusion inhibitor MDT-637 for the treatment of respiratory syncytial virus infection and plans to present data from the three studies at the… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
No events are found.